CATD_HUMAN - dbPTM
CATD_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CATD_HUMAN
UniProt AC P07339
Protein Name Cathepsin D
Gene Name CTSD
Organism Homo sapiens (Human).
Sequence Length 412
Subcellular Localization Lysosome. Melanosome. Secreted, extracellular space. Identified by mass spectrometry in melanosome fractions from stage I to stage IV. In aortic samples, detected as an extracellular protein loosely bound to the matrix (PubMed:20551380).
Protein Description Acid protease active in intracellular protein breakdown. Plays a role in APP processing following cleavage and activation by ADAM30 which leads to APP degradation. [PubMed: 27333034 Involved in the pathogenesis of several diseases such as breast cancer and possibly Alzheimer disease.]
Protein Sequence MQPSSLLPLALCLLAAPASALVRIPLHKFTSIRRTMSEVGGSVEDLIAKGPVSKYSQAVPAVTEGPIPEVLKNYMDAQYYGEIGIGTPPQCFTVVFDTGSSNLWVPSIHCKLLDIACWIHHKYNSDKSSTYVKNGTSFDIHYGSGSLSGYLSQDTVSVPCQSASSASALGGVKVERQVFGEATKQPGITFIAAKFDGILGMAYPRISVNNVLPVFDNLMQQKLVDQNIFSFYLSRDPDAQPGGELMLGGTDSKYYKGSLSYLNVTRKAYWQVHLDQVEVASGLTLCKEGCEAIVDTGTSLMVGPVDEVRELQKAIGAVPLIQGEYMIPCEKVSTLPAITLKLGGKGYKLSPEDYTLKVSQAGKTLCLSGFMGMDIPPPSGPLWILGDVFIGRYYTVFDRDNNRVGFAEAARL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
4Phosphorylation----MQPSSLLPLAL
----CCHHHHHHHHH
19.4124043423
5Phosphorylation---MQPSSLLPLALC
---CCHHHHHHHHHH
40.3824043423
19PhosphorylationCLLAAPASALVRIPL
HHHHCCHHHHHHCCH
22.5224043423
28UbiquitinationLVRIPLHKFTSIRRT
HHHCCHHHHHHHHHH
59.0021890473
30PhosphorylationRIPLHKFTSIRRTMS
HCCHHHHHHHHHHHH
28.2223909892
31PhosphorylationIPLHKFTSIRRTMSE
CCHHHHHHHHHHHHH
19.7529496963
35PhosphorylationKFTSIRRTMSEVGGS
HHHHHHHHHHHCCCC
18.3921406692
37PhosphorylationTSIRRTMSEVGGSVE
HHHHHHHHHCCCCHH
28.6321406692
42PhosphorylationTMSEVGGSVEDLIAK
HHHHCCCCHHHHHHC
19.1920068231
49UbiquitinationSVEDLIAKGPVSKYS
CHHHHHHCCCCHHHC
57.67-
53PhosphorylationLIAKGPVSKYSQAVP
HHHCCCCHHHCCCCC
29.0729116813
54UbiquitinationIAKGPVSKYSQAVPA
HHCCCCHHHCCCCCC
49.5121890473
56PhosphorylationKGPVSKYSQAVPAVT
CCCCHHHCCCCCCCC
18.5229116813
63O-linked_GlycosylationSQAVPAVTEGPIPEV
CCCCCCCCCCCCHHH
37.0155825339
63PhosphorylationSQAVPAVTEGPIPEV
CCCCCCCCCCCCHHH
37.0129116813
1222-HydroxyisobutyrylationIACWIHHKYNSDKSS
HHHHHHHHCCCCCCC
31.78-
1272-HydroxyisobutyrylationHHKYNSDKSSTYVKN
HHHCCCCCCCEEEEC
46.24-
127UbiquitinationHHKYNSDKSSTYVKN
HHHCCCCCCCEEEEC
46.24-
134N-linked_GlycosylationKSSTYVKNGTSFDIH
CCCEEEECCEEEEEE
49.268393577
134N-linked_GlycosylationKSSTYVKNGTSFDIH
CCCEEEECCEEEEEE
49.268393577
165O-linked_GlycosylationVPCQSASSASALGGV
CCCCCCCCCHHHCCC
26.42OGP
184UbiquitinationQVFGEATKQPGITFI
EECCCCCCCCCEEEE
62.6421890473
203PhosphorylationDGILGMAYPRISVNN
CCCCCCCCCEEECCC
5.5525599653
219SulfoxidationLPVFDNLMQQKLVDQ
HHHHHHHHHHHCCCC
5.0728465586
230PhosphorylationLVDQNIFSFYLSRDP
CCCCCCHHEECCCCC
14.8025867546
232PhosphorylationDQNIFSFYLSRDPDA
CCCCHHEECCCCCCC
11.5425867546
234PhosphorylationNIFSFYLSRDPDAQP
CCHHEECCCCCCCCC
24.2125867546
246SulfoxidationAQPGGELMLGGTDSK
CCCCCEEECCCCCCC
2.5828465586
250PhosphorylationGELMLGGTDSKYYKG
CEEECCCCCCCCCCC
34.9923911959
252PhosphorylationLMLGGTDSKYYKGSL
EECCCCCCCCCCCCE
23.5423911959
2532-HydroxyisobutyrylationMLGGTDSKYYKGSLS
ECCCCCCCCCCCCEE
56.24-
253UbiquitinationMLGGTDSKYYKGSLS
ECCCCCCCCCCCCEE
56.2421890473
254PhosphorylationLGGTDSKYYKGSLSY
CCCCCCCCCCCCEEE
17.8625219547
255PhosphorylationGGTDSKYYKGSLSYL
CCCCCCCCCCCEEEE
16.7725219547
258PhosphorylationDSKYYKGSLSYLNVT
CCCCCCCCEEEEEEC
15.2525219547
260PhosphorylationKYYKGSLSYLNVTRK
CCCCCCEEEEEECCC
29.3128060719
261PhosphorylationYYKGSLSYLNVTRKA
CCCCCEEEEEECCCE
13.9528060719
263N-linked_GlycosylationKGSLSYLNVTRKAYW
CCCEEEEEECCCEEE
25.538393577
263N-linked_GlycosylationKGSLSYLNVTRKAYW
CCCEEEEEECCCEEE
25.538393577
265PhosphorylationSLSYLNVTRKAYWQV
CEEEEEECCCEEEEE
25.9428060719
269PhosphorylationLNVTRKAYWQVHLDQ
EEECCCEEEEEEHHH
10.2125219547
301SulfoxidationVDTGTSLMVGPVDEV
EECCCCEEEECHHHH
3.0730846556
313UbiquitinationDEVRELQKAIGAVPL
HHHHHHHHHHCCCCE
55.38-
325PhosphorylationVPLIQGEYMIPCEKV
CCEECCEEEEECCCC
13.73-
326SulfoxidationPLIQGEYMIPCEKVS
CEECCEEEEECCCCC
2.1028465586
329GlutathionylationQGEYMIPCEKVSTLP
CCEEEEECCCCCCCC
5.6722555962
331UbiquitinationEYMIPCEKVSTLPAI
EEEEECCCCCCCCEE
48.48-
333PhosphorylationMIPCEKVSTLPAITL
EEECCCCCCCCEEEE
34.9823911959
334PhosphorylationIPCEKVSTLPAITLK
EECCCCCCCCEEEEE
39.4823911959
339PhosphorylationVSTLPAITLKLGGKG
CCCCCEEEEEECCCC
21.6820071362
341UbiquitinationTLPAITLKLGGKGYK
CCCEEEEEECCCCEE
36.11-
341MalonylationTLPAITLKLGGKGYK
CCCEEEEEECCCCEE
36.1130639696
347PhosphorylationLKLGGKGYKLSPEDY
EEECCCCEECCHHHE
16.55-
348UbiquitinationKLGGKGYKLSPEDYT
EECCCCEECCHHHEE
51.6721890473
354PhosphorylationYKLSPEDYTLKVSQA
EECCHHHEEEEEECC
16.59-
357UbiquitinationSPEDYTLKVSQAGKT
CHHHEEEEEECCCCE
31.85-
359PhosphorylationEDYTLKVSQAGKTLC
HHEEEEEECCCCEEE
16.8424247654
394PhosphorylationDVFIGRYYTVFDRDN
CEEEECEEEEEECCC
8.62-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of CATD_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of CATD_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CATD_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
PPGB_HUMANCTSAphysical
22939629
ACADM_HUMANACADMphysical
26344197
ETFA_HUMANETFAphysical
26344197
GRHPR_HUMANGRHPRphysical
26344197
ENPL_HUMANHSP90B1physical
26344197
PCBP1_HUMANPCBP1physical
26344197
RAB5A_HUMANRAB5Aphysical
26344197
SCNNG_HUMANSCNN1Gphysical
26344197
SCYL2_HUMANSCYL2physical
26344197
QCR2_HUMANUQCRC2physical
26344197
SYUA_HUMANSNCAphysical
25617759

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
610127Ceroid lipofuscinosis, neuronal, 10 (CLN10)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CATD_HUMAN

loading...

Related Literatures of Post-Translational Modification
N-linked Glycosylation
ReferencePubMed
"Crystal structures of native and inhibited forms of human cathepsinD: implications for lysosomal targeting and drug design.";
Baldwin E.T., Bhat T.N., Gulnik S., Hosur M.V., Sowder R.C. II,Cachau R.E., Collins J., Silva A.M., Erickson J.W.;
Proc. Natl. Acad. Sci. U.S.A. 90:6796-6800(1993).
Cited for: X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS).
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry.";
Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
J. Proteome Res. 8:651-661(2009).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-134 AND ASN-263, AND MASSSPECTROMETRY.
"Elucidation of N-glycosylation sites on human platelet proteins: aglycoproteomic approach.";
Lewandrowski U., Moebius J., Walter U., Sickmann A.;
Mol. Cell. Proteomics 5:226-233(2006).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-263, AND MASSSPECTROMETRY.
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry.";
Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.;
J. Proteome Res. 4:2070-2080(2005).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-263, AND MASSSPECTROMETRY.
"Identification and quantification of N-linked glycoproteins usinghydrazide chemistry, stable isotope labeling and mass spectrometry.";
Zhang H., Li X.-J., Martin D.B., Aebersold R.;
Nat. Biotechnol. 21:660-666(2003).
Cited for: GLYCOSYLATION AT ASN-263.

TOP